10 Geographic Atrophy Clinical Trials in Stanford, CA (2026)

Q: How do I join a clinical trial in Stanford?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you.

Recruiting Geographic Atrophy Studies in Stanford

NCT06926868Recruiting

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

The purpose of this study is to assess the efficacy and safety of iza-bren, a bi-specific antibody-drug conjugate against EGFR and HER3 with a topoisomerase inhibitor payload versus treatment of physi...

Stanford, CAPHASE2600 participantsBristol-Myers Squibb

View Study Details

NCT04191551Recruiting

The GAstric Precancerous Conditions Study

Gastric cancer afflicts 27,000 Americans annually and carries a dismal prognosis. One reason for poor outcomes is late diagnosis, as the majority of gastric cancers in the United States are diagnosed ...

Stanford, CA600 participantsStanford University

View Study Details

NCT01514045Recruiting

The Gastric Cancer Foundation: A Gastric Cancer Registry

The Gastric Cancer Registry will combine data acquired directly from patients with gastric cancer; with a family history of gastric cancer in a first or second degree relative; or persons with a known...

Stanford, CA500 participantsStanford University

View Study Details

NCT05947071Recruiting

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

Influenza virus is a significant pathogen in pediatric solid organ transplant (SOT) recipients. However, these individuals respond poorly to standard-dose (SD) inactivated influenza vaccine (IIV). Rec...

Stanford, CAPHASE2312 participantsNational Institute of Allergy and Infectious Diseases (NIAID)

View Study Details

NCT02774746Recruiting

Gastroschisis Outcomes of Delivery (GOOD) Study

The objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectant management with a goal...

Stanford, CANA300 participantsMedical College of Wisconsin

View Study Details

NCT06671639Recruiting

Stanford Program to Accelerate Robotic Children's Surgery

The goal of this clinical trial is to provide additional data to confirm safety and performance of the da Vinci Xi Surgical System in a human clinical setting. This pilot study is intended to provide ...

Stanford, CANA250 participantsStanford University

View Study Details

NCT07015424Recruiting

Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric Bypass

The goal of this clinical trial is to evaluate weight loss with TORe and intensive lifestyle modification versus intensive lifestyle modification alone in subjects who have regained weight following a...

Stanford, CANA108 participantsBoston Scientific Corporation

View Study Details

NCT03520374Recruiting

Bedside Ultrasound of Gastric Contents in Pediatric Populations

Perioperative aspiration of gastric contents is a rare but serious adverse event. The risk of aspiration can be estimated by perioperative evaluation of stomach contents with ultrasound using a valida...

Stanford, CANA60 participantsStanford University

View Study Details

NCT03552705Recruiting

The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients

Patients who tear their ACL are at high risk for developing arthritis (post-traumatic osteoarthritis-PTOA) just 10 years later. Joint bleeding and inflammation contribute to deterioration of joint hea...

Stanford, CAPHASE250 participantsStanford University

View Study Details

NCT04768426Recruiting

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

The purpose of the study is to evaluate the use of a circulating tumor DNA (ctDNA) assay, ie, a "liquid biopsy," as a tool to identify triple-negative breast cancer (TNBC) patients who will or will no...

Stanford, CAPHASE240 participantsStanford University

View Study Details

About Geographic Atrophy Clinical Trials in Stanford

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 10 geographic atrophy clinical trials recruiting participants in Stanford, CA. These studies are seeking a combined 2,820 participants. Research is being sponsored by Bristol-Myers Squibb, Stanford University, National Institute of Allergy and Infectious Diseases (NIAID) and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Stanford — FAQ

Are there geographic atrophy clinical trials in Stanford?

Yes, there are 10 geographic atrophy clinical trials currently recruiting in Stanford, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Stanford?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Stanford research site will contact you about next steps.

Are clinical trials in Stanford free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Stanford studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 10 active trials in Stanford are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 12, 2026 from ClinicalTrials.gov